medlr news Peptris Technologies Licenses India’s First AI-Discovered Drug to Revio Therapeutics Peptris Technologies partners with Revio Therapeutics to advance PEPR124 (RT001), India’s first AI-discovered drug candidate for Duchenne muscular dystrophy (DMD). The agreement accelerates AI-driven drug discovery and expands global biotech reach.
News Peptris Secures $1M in VC Funding to Propel AI-Driven Drug Discovery Peptris Technologies' recent $1 million pre-seed funding, spearheaded by Speciale Invest, fuels their AI-driven drug discovery efforts.
